These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24909304)

  • 1. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
    Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
    Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
    Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.
    Polverino E; Cillóniz C; Dambrava P; Gabarrús A; Ferrer M; Agustí C; Prina E; Montull B; Menendez R; Niederman MS; Torres A
    Respirology; 2013 Feb; 18(2):263-71. PubMed ID: 23134361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
    Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
    Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia.
    Singanayagam A; Chalmers JD; Akram AR; Hill AT
    Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.
    Cilli A; Erdem H; Karakurt Z; Turkan H; Yazicioglu-Mocin O; Adiguzel N; Gungor G; Bilge U; Tasci C; Yilmaz G; Oncul O; Dogan-Celik A; Erdemli O; Oztoprak N; Samur AA; Tomak Y; Inan A; Karaboga B; Tok D; Temur S; Oksuz H; Senturk O; Buyukkocak U; Yilmaz-Karadag F; Ozcengiz D; Karakas A; Savasci U; Ozgen-Alpaydın A; Kilic E; Elaldi N; Bilgic H
    J Crit Care; 2013 Dec; 28(6):975-9. PubMed ID: 24075301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia.
    Sellares J; López-Giraldo A; Lucena C; Cilloniz C; Amaro R; Polverino E; Ferrer M; Menéndez R; Mensa J; Torres A
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1241-8. PubMed ID: 23590264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of systemic corticosteroid administration in the prognosis of patients with community-acquired pneumonia].
    Fernández-Herranz J; de Miguel-Díez J; Del Castillo-Rueda A; Bellón-Cano JM; Jiménez-García R; Alvarez-Sala-Walther LA
    Rev Clin Esp; 2012 Jul; 212(7):337-43. PubMed ID: 22621712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.
    Eurich DT; Lee C; Marrie TJ; Majumdar SR
    Clin Infect Dis; 2013 Oct; 57(8):1138-44. PubMed ID: 23872948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation.
    Crisafulli E; Guerrero M; Menéndez R; Huerta A; Martinez R; Gimeno A; Soler N; Torres A
    Respir Care; 2014 Oct; 59(10):1550-9. PubMed ID: 25074943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study.
    Dusemund F; Chronis J; Baty F; Albrich WC; Brutsche MH
    Swiss Med Wkly; 2014; 144():w14013. PubMed ID: 25184329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients.
    Bacci MR; Leme RC; Zing NP; Murad N; Adami F; Hinnig PF; Feder D; Chagas AC; Fonseca FL
    Braz J Med Biol Res; 2015 May; 48(5):427-32. PubMed ID: 25714883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma.
    To M; To Y; Yamada H; Ogawa C; Otomo M; Suzuki N; Sano Y
    Intern Med; 2004 Aug; 43(8):674-8. PubMed ID: 15468964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.
    Remmelts HH; Meijvis SC; Heijligenberg R; Rijkers GT; Oosterheert JJ; Bos WJ; Endeman H; Grutters JC; Hoepelman AI; Biesma DH
    J Infect; 2012 Jul; 65(1):25-31. PubMed ID: 22410382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD is associated with increased mortality in patients with community-acquired pneumonia.
    Restrepo MI; Mortensen EM; Pugh JA; Anzueto A
    Eur Respir J; 2006 Aug; 28(2):346-51. PubMed ID: 16611653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S; Plauschinat CA; Wu N; Fraser K; Boulanger L
    J Med Econ; 2011; 14(4):458-62. PubMed ID: 21651427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.